Parametric Portfolio Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $210M | Sell |
|
|||||
|
2021
Q4 | $312M | Buy |
|
|||||
|
2021
Q3 | $284M | Sell |
|
|||||
|
2021
Q2 | $458M | Buy |
|
|||||
|
2021
Q1 | $424M | Buy |
|
|||||
|
2020
Q4 | $365M | Buy |
|
|||||
|
2020
Q3 | $374M | Buy |
|
|||||
|
2020
Q2 | $444M | Buy |
|
|||||
|
2020
Q1 | $399M | Buy |
|
|||||
|
2019
Q4 | $302M | Sell |
|
|||||
|
2019
Q3 | $304M | Buy |
|
|||||
|
2019
Q2 | $320M | Buy |
|
|||||
|
2019
Q1 | $274M | Buy |
|
|||||
|
2018
Q4 | $259M | Sell |
|
|||||
|
2018
Q3 | $330M | Buy |
|
|||||
|
2018
Q2 | $283M | Sell |
|
|||||
|
2018
Q1 | $313M | Buy |
|
|||||
|
2017
Q4 | $278M | Buy |
|
|||||
|
2017
Q3 | $287M | Buy |
|
|||||
|
2017
Q2 | $217M | Buy |
|
|||||
|
2017
Q1 | $151M | Sell |
|
|||||
|
2016
Q4 | $236M | Buy |
|
|||||
|
2016
Q3 | $238M | Sell |
|
|||||
|
2016
Q2 | $259M | Buy |
|
|||||
|
2016
Q1 | $277M | Sell |
|
|||||
|
2015
Q4 | $340M | Buy |
|
|||||
|
2015
Q3 | $324M | Buy |
|
|||||
|
2015
Q2 | $320M | Buy |
|
|||||
|
2015
Q1 | $258M | Buy |
|
|||||
|
2014
Q4 | $232M | Sell |
|
|||||
|
2014
Q3 | $278M | Sell |
|
|||||
|
2014
Q2 | $223M | Sell |
|
|||||
|
2014
Q1 | $196M | Buy |
|
|||||
|
2013
Q4 | $202M | Buy |
|
|||||
|
2013
Q3 | $165M | Buy |
|
|||||
|
2013
Q2 | $131M | Buy |
|